Pharmala Biotech Holdings Inc. (CSE:MDMA)
 0.1150
 +0.0050 (4.55%)
  Oct 31, 2025, 1:13 PM EDT
Pharmala Biotech Holdings Revenue
Pharmala Biotech Holdings had revenue of 135.17K CAD in the quarter ending May 31, 2025, a decrease of -6.48%. This brings the company's revenue in the last twelve months to 420.81K, down -69.75% year-over-year. In the fiscal year ending August 31, 2024, Pharmala Biotech Holdings had annual revenue of 1.04M with 94.60% growth.
Revenue (ttm) 
 420.81K
Revenue Growth 
 -69.75%
P/S Ratio 
 28.39
Revenue / Employee 
 n/a
Employees 
 n/a
Market Cap 
11.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Aug 31, 2024 | 1.04M | 503.29K | 94.60% | 
| Aug 31, 2023 | 532.00K | 453.93K | 581.44% | 
| Aug 31, 2022 | 78.07K | - | - | 
| Aug 31, 2021 | - | - | - | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition